A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.

The Three Volcanoes Park LLC  will build a world-class tourism cluster in the area of Vilyuchinsky, Mutnovsky and Gorely volcanoes, with access to Vilyuchinsky Bay.

Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.

The common take-away was that «to become nature lovers, people need to have access to nature». Thus, the number one task is to create a legislative framework, currently all but non-existent.

Sergey Tyrtsev, First Deputy Minister for Development of the Russian Far East and Arctic; Zarina Doguzova, head of Rostourism; Vladimir Ilyukhin, Governor of the Kamchatka region; and Sergey Bachin, Chairman of the Board of the «Three Volcanoes Park», signed the strategic cooperation agreement at the Eastern Economic Forum in order to launch an investment project to create a world-class resort and accessible-to-all recreation infrastructure around the Mutnovsky, Vilyuchinsky and Gorely volcanoes of the Three Volcanoes Park.